about
Metal- and Semimetal-Containing Inhibitors of Thioredoxin Reductase as Anticancer AgentsArsenic exposure predicts bladder cancer survival in a US populationTargeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.Induction of cyclin D1 by arsenite and UVB-irradiation in human keratinocytesArsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growthEffect of Sodium Arsenite on Mouse Skin Carcinogenesis.Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.Silymarin protects plasma membrane and acrosome integrity in sperm treated with sodium arseniteThe use of glutathione transferase-knockout mice as pharmacological and toxicological models.Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role.Arsenic-based antineoplastic drugs and their mechanisms of action.Extraction tool and matrix effects on arsenic speciation analysis in cell lines.Curcumin Inhibits The Adverse Effects of Sodium Arsenite in Mouse Epididymal Sperm.Speciation, formation, stability and analytical challenges of human arsenic metabolites.Effect of vitamin E on sperm parameters and DNA integrity in sodium arsenite-treated rats.Antibacterial evaluation of novel organoarsenic compounds by the microcalorimetric method.Effect of sodium arsenite on reproductive organs of female Wistar rats.
P2860
Q26800031-AD47E831-D6EF-47C7-9116-1A9E4E1DE321Q28397390-154E2795-7DDE-46D6-9337-039BC58E7DD2Q33291299-759B79A0-3364-471E-987E-7ABDC2E7A4B1Q33915879-FDE6C6AB-D8C5-4FED-AE78-685B415715EFQ33976179-4400CA9C-E5F6-4291-839B-3FB3D9D0D3BAQ35563733-3D625FE5-7149-4BC8-A809-A39563FEA42EQ35984173-0DBAA9D1-00EA-4274-8D6C-981066A7BA68Q36007574-14551E6E-E854-4535-849E-BB38659E068AQ36835830-DBD93DD8-6A24-44E4-86F4-8AC3B73C2A3FQ37085878-95079E81-4D8C-4BAC-9A7D-27A5E3866734Q37145891-D25B3CD9-BEF1-4F86-A58F-CBC99CE97CB2Q38603464-98AED68B-3E10-413F-8385-AFDFF582720AQ39577838-4A935F93-9DF0-482D-8F12-142D358D3D7EQ41240008-D6F8560D-254D-4B01-AA06-715CE3381BDDQ42882234-584F41B3-9DEF-45F4-8F49-59B2B1883CBFQ43823358-2B4DC73D-5FD7-40C1-B6B9-799841256340Q48067237-F7667975-30E3-49AB-896A-3848FA32ADB6
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Arsenic in cancer therapy
@ast
Arsenic in cancer therapy
@en
Arsenic in cancer therapy
@nl
type
label
Arsenic in cancer therapy
@ast
Arsenic in cancer therapy
@en
Arsenic in cancer therapy
@nl
prefLabel
Arsenic in cancer therapy
@ast
Arsenic in cancer therapy
@en
Arsenic in cancer therapy
@nl
P2093
P1433
P1476
Arsenic in cancer therapy
@en
P2093
P304
P356
10.1097/00001813-200502000-00002
P407
P577
2005-02-01T00:00:00Z